COMPANY PROFILE

Neurent Medical

Explore full profile

Pioneering innovative treatments for chronic inflammatory sino-nasal diseases.

Oranmore, IrelandFounded 2015Health Tech & Medtech

Valuation $250–500M Last recorded · 2026

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Neurent Medical

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. NEUROMARK is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: Oranmore, Ireland
Employees: 80
Open positions: None listed
Dealroom signal: 93.5/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Medical & Healthcare, Patient Care, Inflammatory Diseases, Chronic Disease, Spinout, Tech for Hospitals and Clinics, EIT Health, biotech medtech and e-health
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GROWTH EQUITY VCOther financing	Feb 2026	$69M	—	Enterprise Ireland · MVM Life Science Partners · Sofinnova Partners · Atlantic Bridge	↗
GROWTH EQUITY VCOther financing	Dec 2024	$9M	—	Claret Capital Partners	↗

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	Margin
2026
2025
2024
2023
2022		—
2021	—	—	—
2020	—	—	—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Neurent Medical website traffic

Latest recorded traffic for Neurent Medical is 5.2K monthly website visits, down 34.2% over the last three months. Neurent Medical's team grew 25% over the past year.

Latest monthly visits5.2K 3-month web change-34.2% 1-year team growth+25%

Monthly website visitsNov 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
GRGraphealGrapheal develops and manufactures true monolayer graphene on flexible substrates, enabling next-generation sustainable and cost-effective sensor platforms especially when coupled with IOTs	Grenoble, France	Operational	9	$4.6M	$8.4M
SMSymPhysis MedicalIndependence through Innovation	Galway, Ireland	Operational
IMImageensBuilding the future of healthcare with smart medical imaging data	Paris, France	Operational
INinHEARTAI-enabled digital twin of the heart	Pessac, France	Operational
OROrixhaDeveloping the LV4C (Liquid Ventilation for Cooling) medical device to almost immediately protect the vital organs, in particular the brain and heart	Saint-Cyr-au-Mont-d'Or, France	Operational
IAInterlinked ABReLink features a self-sealable, double-valve system that reduces spillage in the event of a accidental catheter dislodgement	Stockholms kommun, Sweden	Operational
KRKroniKareAn AI-based assessment and management technology for chronic wound care	Singapore, Singapore	Operational
MEMedicsenNeedle-free drug delivery platform based on sonophoresis (ultrasounds) to replace needles and cannulas in the transdermal delivery of large molecules	Madrid, Spain	Operational